Wonbiogen Past Earnings Performance
Past criteria checks 4/6
Wonbiogen has been growing earnings at an average annual rate of 114.1%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 30.1% per year. Wonbiogen's return on equity is 18.3%, and it has net margins of 18.6%.
Key information
114.1%
Earnings growth rate
119.5%
EPS growth rate
Medical Equipment Industry Growth | 22.7% |
Revenue growth rate | 30.1% |
Return on equity | 18.3% |
Net Margin | 18.6% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Wonbiogen makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 29,615 | 5,497 | 6,051 | 504 |
30 Sep 23 | 27,891 | 4,301 | 6,090 | 507 |
30 Jun 23 | 27,782 | 5,227 | 6,225 | 556 |
31 Mar 23 | 27,526 | 3,913 | 6,306 | 482 |
31 Dec 22 | 26,748 | 3,206 | 6,459 | 492 |
30 Sep 22 | 26,543 | 3,455 | 6,790 | 486 |
30 Jun 22 | 24,376 | 2,507 | 6,522 | 415 |
31 Mar 22 | 21,868 | 2,368 | 5,655 | 527 |
31 Dec 21 | 17,721 | -716 | 4,573 | 585 |
30 Sep 21 | 15,390 | -9,681 | 3,026 | 448 |
30 Jun 21 | 14,048 | -9,224 | 2,206 | 487 |
31 Mar 21 | 12,111 | -14,361 | 1,636 | 493 |
31 Dec 20 | 12,018 | -11,662 | 1,573 | 489 |
Quality Earnings: A307280 has high quality earnings.
Growing Profit Margin: A307280's current net profit margins (18.6%) are higher than last year (12%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A307280 has become profitable over the past 5 years.
Accelerating Growth: Insufficient data to compare A307280's past year earnings growth to its 5-year average.
Earnings vs Industry: A307280 earnings growth over the past year (71.5%) exceeded the Medical Equipment industry 8.8%.
Return on Equity
High ROE: A307280's Return on Equity (18.3%) is considered low.